Michael E. Castagna, PharmD

2019

In 2019, Michael E. Castagna, PharmD earned a total compensation of $1.6M as Chief Executive Officer at MannKind, a 3% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$285,117
Option Awards$617,568
Salary$510,962
Stock Awards$90,000
Other$48,118
Total$1,551,765

PharmD received $617.6K in option awards, accounting for 40% of the total pay in 2019.

PharmD also received $285.1K in non-equity incentive plan, $511K in salary, $90K in stock awards and $48.1K in other compensation.

Rankings

In 2019, Michael E. Castagna, PharmD's compensation ranked 7,162nd out of 13,971 executives tracked by ExecPay. In other words, PharmD earned more than 48.7% of executives.

ClassificationRankingPercentile
All
7,162
out of 13,971
49th
Division
Manufacturing
2,758
out of 5,695
52nd
Major group
Chemicals And Allied Products
1,021
out of 2,194
54th
Industry group
Drugs
866
out of 1,880
54th
Industry
Pharmaceutical Preparations
638
out of 1,392
54th

Pay ratio

Michael E. Castagna, PharmD's Pay$1,551,765
Median Employee's Pay$148,059
Pay Ratio

10

to 1

In 2019, the annual total compensation of Michael E. Castagna, PharmD was $1,551,765.

The annual total compensation of the median employee at MannKind was $148,059.

The ratio of Michael E. Castagna, PharmD's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 10, 2020.

PharmD's colleagues

We found four more compensation records of executives who worked with Michael E. Castagna, PharmD at MannKind in 2019.

2019

David Kendall

MannKind

Chief Medical Officer

2019

David Thomson

MannKind

General Counsel

2019

Steven Binder

MannKind

Chief Financial Officer

2019

James McCauley

MannKind

Chief Commercial Officer

News

You may also like